SG10201407496SA - Drug Combination With Theobromine And Its Use In Therapy - Google Patents

Drug Combination With Theobromine And Its Use In Therapy

Info

Publication number
SG10201407496SA
SG10201407496SA SG10201407496SA SG10201407496SA SG10201407496SA SG 10201407496S A SG10201407496S A SG 10201407496SA SG 10201407496S A SG10201407496S A SG 10201407496SA SG 10201407496S A SG10201407496S A SG 10201407496SA SG 10201407496S A SG10201407496S A SG 10201407496SA
Authority
SG
Singapore
Prior art keywords
theobromine
therapy
drug combination
drug
combination
Prior art date
Application number
SG10201407496SA
Other languages
English (en)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of SG10201407496SA publication Critical patent/SG10201407496SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG10201407496SA 2009-11-13 2010-11-12 Drug Combination With Theobromine And Its Use In Therapy SG10201407496SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
SG10201407496SA true SG10201407496SA (en) 2015-02-27

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201407496SA SG10201407496SA (en) 2009-11-13 2010-11-12 Drug Combination With Theobromine And Its Use In Therapy

Country Status (19)

Country Link
EP (1) EP2498776A1 (enExample)
JP (2) JP2013510842A (enExample)
CN (1) CN102740853B (enExample)
AU (1) AU2010317668C1 (enExample)
BR (1) BR112012011224A2 (enExample)
CA (1) CA2780704C (enExample)
CO (1) CO6551745A2 (enExample)
EC (2) ECSP12011892A (enExample)
GB (1) GB0919893D0 (enExample)
IL (1) IL219769A0 (enExample)
MX (1) MX2012005538A (enExample)
NZ (1) NZ599957A (enExample)
PE (1) PE20121472A1 (enExample)
PH (1) PH12012500955A1 (enExample)
RU (1) RU2587329C2 (enExample)
SG (1) SG10201407496SA (enExample)
UA (1) UA105940C2 (enExample)
WO (1) WO2011058374A1 (enExample)
ZA (1) ZA201204247B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108064T1 (de) * 1987-10-08 1994-07-15 Andor Bilas Stoffgemisch zur stabilisierung der stoffwechsel- lage.
CA2170488A1 (en) * 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
ES2528384T3 (es) * 2001-12-12 2015-02-09 The Government Of The United States Of America, As Represented By The Secretary Department Of Healt Métodos de utilización de inhibidores del receptor de adenosina para potenciar la respuesta inmunitaria y la inflamación
AU2004216550B2 (en) * 2003-02-28 2010-06-03 Ym Biosciences Inc. Opioid delivery system
CN1593451A (zh) * 2003-09-12 2005-03-16 杨喜鸿 促进男性勃起的外用药物
JPWO2006064780A1 (ja) * 2004-12-14 2008-06-12 塩野義製薬株式会社 便秘治療剤
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물

Also Published As

Publication number Publication date
CA2780704A1 (en) 2011-05-19
ZA201204247B (en) 2013-02-27
EP2498776A1 (en) 2012-09-19
CA2780704C (en) 2018-07-17
AU2010317668C1 (en) 2016-02-11
IL219769A0 (en) 2012-07-31
RU2012124063A (ru) 2013-12-20
CN102740853A (zh) 2012-10-17
PE20121472A1 (es) 2012-11-30
JP2013510842A (ja) 2013-03-28
RU2587329C2 (ru) 2016-06-20
UA105940C2 (uk) 2014-07-10
GB0919893D0 (en) 2009-12-30
WO2011058374A1 (en) 2011-05-19
CN102740853B (zh) 2015-04-08
ECSP12011892A (es) 2012-09-28
CO6551745A2 (es) 2012-10-31
NZ599957A (en) 2014-05-30
AU2010317668A1 (en) 2012-06-07
JP2016041748A (ja) 2016-03-31
BR112012011224A2 (pt) 2017-03-01
AU2010317668B2 (en) 2015-01-22
ECSP12011893A (es) 2012-10-30
PH12012500955A1 (en) 2013-01-07
MX2012005538A (es) 2012-09-28

Similar Documents

Publication Publication Date Title
IL222006A (en) Pyrulobenzodiazepine conjugates and their use in medicine
IL211952A0 (en) Implantable device for the delivery of risperidone and methods of use thereof
HUE041034T2 (hu) SAP-variánsok és alkalmazásuk
IL214244A0 (en) Scriptaid isosteres and their use in therapy
GB0921803D0 (en) Drug composition and its use in therapy
ZA201204248B (en) Drug combination with theobromine and its use in therapy
IL224953A (en) Theobromine-containing preparations and their use in combination with a debilitating drug
ZA201204247B (en) Drug combination with theobromine and its use in therapy
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
GB2460178B (en) Depsipeptides and their therapeutic use
GB2460181B (en) Depsipeptides and their therapeutic use
GB0917533D0 (en) Azaphthalocyanines and their use in printing
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB2460180B (en) Depsipeptides and their therapeutic use
GB0818663D0 (en) Gene regulation and its use in therapy
GB0920267D0 (en) Drug combination and its use in therapy
GB0918727D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0909354D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy
EP2234667A4 (en) DETERMINATION AND METHODS OF ADMINISTERING A TREATMENT